Tat Results

SPINK1

serine peptidase inhibitor, Kazal type 1
05/31/2017

STAT1

signal transducer and activator of transcription 1
05/31/2017

TRIM32

tripartite motif containing 32
11/09/2018

TAT

tyrosine aminotransferase
03/08/2019

ATAT1

alpha tubulin acetyltransferase 1

HTATIP2

HIV-1 Tat interactive protein 2

HTATSF1

HIV-1 Tat specific factor 1

KAT5

lysine acetyltransferase 5

SLC16A10

solute carrier family 16 member 10

SOCS2

suppressor of cytokine signaling 2

SOCS6

suppressor of cytokine signaling 6

STAT2

signal transducer and activator of transcription 2

STAT3

signal transducer and activator of transcription 3

STAT4

signal transducer and activator of transcription 4

STAT5A

signal transducer and activator of transcription 5A

STAT5B

signal transducer and activator of transcription 5B

STAT6

signal transducer and activator of transcription 6

STATH

statherin

TATDN1

TatD DNase domain containing 1

TATDN2

TatD DNase domain containing 2

Fanconi anemia complementation group C

MONDO_0009213 Condition
Fanconi anemia complementation group type C
04/19/2019

Fanconi anemia complementation group A

MONDO_0009215 Condition
Fanconi anemia complementation group type A
04/19/2019

Fanconi anemia complementation group G

MONDO_0013565 Condition
Fanconi anemia complementation group type G
04/19/2019

guanidinoacetate methyltransferase deficiency

MONDO_0012999 Condition
Cerebral Creatine Deficiency Syndrome type 2
01/25/2019

Rubinstein-Taybi syndrome due to CREBBP mutations

MONDO_0008393 Condition
Rubinstein-Taybi Syndrome type 1
10/10/2018

Fanconi anemia complementation group D1

MONDO_0011584 Condition
FAD1
04/19/2019

Alagille syndrome due to a NOTCH2 point mutation

MONDO_0012439 Condition
Syndromic bile duct paucity due to a NOTCH2 point mutation
05/31/2017

Alagille syndrome due to a JAG1 point mutation

MONDO_0016862 Condition
Alagille-Watson syndrome due to a JAG1 point mutation
06/01/2017

11/12/2018

congenital stationary night blindness 1B

MONDO_0009758 Condition
CSNB1B
10/15/2018

Fanconi anemia complementation group i

MONDO_0012186 Condition
Fanconi Anemia, Complementation Group type 1
01/07/2019

Fanconi anemia complementation group f

MONDO_0011325 Condition
Fanconi anemia complementation group type F
01/07/2019

X-linked chondrodysplasia punctata 1

MONDO_0010555 Condition
brachytelephalangic chondrodysplasia punctata
05/31/2017

lissencephaly type 1 due to doublecortin gene mutation

MONDO_0010239 Condition
X-linked lissencephaly type 1
06/13/2017

10/18/2018

tall stature-intellectual disability-facial dysmorphism syndrome

MONDO_0014382 Condition
DNMT3A-related overgrowth syndrome
04/29/2018

PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation

MONDO_0014512 Condition
Mental Retardation, Autosomal Dominant type 31
02/07/2018

inherited glutathione synthetase deficiency

MONDO_0017909 Condition
Pyroglutamicaciduria
04/26/2019

Lactate / Urea Topical Cream

RXNORM:379327 Drug

Sodium Acetate 0.0471 MEQ/ML

RXNORM:801384 Drug